In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
As of close of business last night, Janux Therapeutics Inc’s stock clocked out at $24.28, up 4.34% from its previous closing price of $23.27. In other words, the price has increased by $4.34 from its previous closing price. On the day, 0.93 million shares were traded.
Ratios:
To gain a deeper understanding of JANX’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 58.47 and its Current Ratio is at 58.47. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 03, 2024, Reiterated its Buy rating but revised its target price to $70 from $63 previously.
On December 03, 2024, BTIG Research reiterated its Buy rating and also lowered its target price recommendation from $82 to $100.
On November 22, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $79.Leerink Partners initiated its Outperform rating on November 22, 2024, with a $79 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on May 01 ’25 when Meyer Andrew Hollman sold 3,333 shares for $32.03 per share. The transaction valued at 106,745 led to the insider holds 82,139 shares of the business.
ANDREW MEYER bought 3,333 shares of JANX for $110,656 on May 01 ’25. On Apr 21 ’25, another insider, Meyer Andrew Hollman, who serves as the Chief Business Officer of the company, sold 3,334 shares for $30.00 each. As a result, the insider received 100,020 and left with 82,139 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 153.83 while its Price-to-Book (P/B) ratio in mrq is 1.42.
Stock Price History:
Over the past 52 weeks, JANX has reached a high of $71.71, while it has fallen to a 52-week low of $22.48. The 50-Day Moving Average of the stock is -15.85%, while the 200-Day Moving Average is calculated to be -42.60%.
Shares Statistics:
A total of 59.17M shares are outstanding, with a floating share count of 49.57M. Insiders hold about 16.13% of the company’s shares, while institutions hold 110.39% stake in the company.
Earnings Estimates
The company has 7.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.39 and low estimates of -$0.99.
Analysts are recommending an EPS of between -$1.32 and -$3.28 for the fiscal current year, implying an average EPS of -$2.11. EPS for the following year is -$2.82, with 8.0 analysts recommending between -$1.35 and -$4.84.
